Podcast

Saira Sheikh, MD, on More Diverse Clinical Trials Can Lead to Improved Outcomes in Lupus

12/10/2018

 

Dr Saira Sheikh from University of North Carolina at Chapel Hill discusses the lack of diversity in Lupus clinical trials, the new ACR partnership aimed at increasing access to trials, the overall impact on the rheumatologist's ability to manage patients, and more.

 

Saira Sheikh, MD, is a rheumatologist and allergist immunologist, and director of the Lupus and Clinical Trials Programs at UNC Thurston Arthritis Research Center at the University of North Carolina at Chapel Hill in North Carolina.

 

 

Related Content

HIV Management
HIV Management
Douglas S. Kwon, MD, PhD, on HIV Transmission and the Vaginal Microbiome
09/06/2018
Douglas S. Kwon, MD, PhD, from Harvard Medical School discusses his research on how the vaginal microbiome affects HIV transmission in women around the world.
09/06/2018
Preventive Cardiology
Preventive Cardiology
Troponin and CAC Score for Predicting ASCVD Risk
07/22/2021
Michael Blaha, MD, MPH, discusses his team’s study on whether troponin levels and coronary artery calcium score can predict future atherosclerotic cardiovascular disease risk, the use of aspirin and statins...
07/22/2021
Lupus
Lupus
Joan T. Merrill, MD, on Optimal Entry Criteria for Lupus Clinical Trials
08/14/2019
Dr Merrill discusses her research that evaluated different serologic features to encourage more entry in lupus clinical trials of individuals with active disease, and more.
08/14/2019
Cardiovascular Diseases
Cardiovascular Diseases
Laxmi Mehta, MD, on Preventing, Treating Myocardial Infarction in Women
02/01/2019
Dr Laxmi Mehta, from Ohio State University, talks about how treatment options differ between men and women who present with myocardial infarction and how to prevent a subsequent infarction.
02/01/2019
Stress and Burnout
Stress and Burnout
Neeta Garg, MD on Navigating MS Care During the Pandemic
09/02/2020
In this podcast, Dr Garg gives an overview of the impact of the COVID-19 pandemic on multiple sclerosis care, including telemedicine, hospital visits, disease-modifying therapies, and more.
09/02/2020